PFWF Leadership - Tri-Chairs
PFWF Council is led by three tri-chairs: the Chair, the Chair-Elect, and the Past Chair. The bio information for the current leadership is below.
PFWF Chair: Jessa Lingel, Ph.D.
Jessa Lingel’s research focuses on digital culture and technological distributions of power. She uses qualitative and interpretive methods to understand relationships between people and technologies.
Jessa Lingel is an associate professor at the Annenberg School for Communication, where she studies digital culture, looking for the ways that relationships to technology can show us gaps in power or possibilities for social change. She received her Ph.D. in Communication and Information from Rutgers University. She has an M.L.I.S. from Pratt Institute and an M.A. from New York University.
Lingel’s research focuses on three key areas: alterity and appropriation, and investigations of how information and technology is altered, tinkered with, subverted, and articulated by marginalized groups; politics of infrastructure, where systems of categorization, organization, and design can reveal underlying ideologies and logics; and technological activism as a way of exploring how socio-technical practices can contribute to projects of social justice.
In her activist work, Lingel concentrates on prison abolition, libraries as vehicles for DIY education, and local access to mental health resources.
PFWF Chair-Elect: Fusun Ozer, DMD, PhD
Dr. Fusun Ozer is a Professor of Restorative Dentistry at Penn Dental Medicine. Prior to joining Penn Dental Medicine in 2008, Dr. Ozer was at Selcuk University Faculty of Dentistry in Turkey, where she served as Chair of Restorative Dentistry for 10 years. She completed her residency and PhD degree in Operative Dentistry at the Marmara University Faculty of Dentistry in 1991. Dr. Ozer has a broad research background in adhesive dentistry, with specific training and expertise in research areas of material adhesion and developing more biologically stable adhesive/dentin interface. Her recent research interests focus on the effect of zeolite incorporation on the long-term antibacterial and anticariogenic properties of silver reinforced glass ionomer cements. One of her research projects also involves ZIF-8 as a pH-responsive nanoplatform for 5-fluorouracil delivery in the chemotherapy of oral squamous cell carcinoma. Dr. Ozer also conducts various company related clinical research studies. She works on several collaborative research projects with national and international researchers from different institutions and published a large number of peer-reviewed papers in the area of dental materials and particularly in Adhesive Dentistry.
PFWF Past-Chair: Monisha Kumar, MD
Dr. Kumar is a neurointensivist and clinical researcher whose area of expertise is in coagulation derangements associated with severe brain injury. She is triple boarded in Neurology, Vascular Neurology and Neurocritical Care. She is an Associate Professor of Neurology, Neurosurgery and Anesthesiology and Critical Care, Vice Chair of Quality for the Department of Neurology, Director of the HUP Neuro ICU, the Physician Lead of the HUP Neuroscience Clinical Effectiveness Team and the former Director of the Penn Neurocritical Care (NCC) Fellowship Program. She has devoted her life to promoting and advancing women of all stripes. She obtained a Bachelor of Arts degree at the University of Michigan and was the first person to create a concentration in Women’s Health and Women’s Studies in the Honors College. She obtained the Doctor of Medicine degree from Medical College of Pennsylvania (MCP)-Hahnemann School of Medicine, a school she intentionally chose for its commitment to the education of women and the care of the underserved. She is passionate about community service and social justice. She completed a residency program in Neurology at MCP-Hahnemann and completed fellowship training in Neurocritical Care at the joint Massachusetts General Hospital/Brigham and Women’s Hospital Partner’s Program. During her tenure at Stanford University, she was part of an all-woman clinical division which was in many ways, revolutionary, for such a nascent field.
As the Director of the Penn Neurocritical Care Fellowship, the top-ranked program consistently matched more women than men, likely due to the influence and optics of a woman in leadership. As the first woman ICU Director at HUP, she served on the COVID Clinician Surge Council and helped lead Penn Medicine’s response to the pandemic. She also spear-headed the transition of inpatient clinical Neurosciences to the New HUP Pavilion. As a member of the Neurology Department’s IDARE (Inclusion, Diversity and Anti-Racism Efforts) Steering Committee and Co-Chair of the IDARE subcommittee on Intradepartmental Equity, she worked to standardize the procedure for requesting Family Medical Leave, updated the verbiage of departmental policies to be modern and inclusive, created forums for non-physician members of the department, identified funds for the professional development of staff, and sought out awards to recognize the contributions of URM staff. She serves on the scientific programming committee for the American Stroke Association, on the Neuroscience Section of the Society for Critical Care Medicine (SCCM) and on the Board of Directors of the Neurocritical Care Society (NCS). She was the former chair of the NCS Guidelines Committee and is chairing the guideline update on anticoagulant reversal in intracranial hemorrhage, a joint venture between SCCM and NCS. During her tenure as the Neurocritical Care Society’s Guidelines Committee Co-Chair she worked to increase women’s representation on both international guidelines and in leadership positions and participated in research chronicling gender representation on international guidelines.
